Ionq, INC Form 4 insider transactions

IonQ's Chief Financial Officer, Thomas G. Kramer, sold 17,776 shares of common stock for approximately $41.28 per share under a pre-arranged trading plan.

IonQ Director Inder M. Singh exercised stock options and subsequently sold a significant portion of common stock under a pre-arranged trading plan.

IonQ Director Gabrielle Toledano received a grant of 3,696 restricted stock units, vesting over three years, as reported in a recent SEC Form 4 filing.

IonQ's Chief Financial Officer, Thomas G. Kramer, sold 47,478 shares of common stock for approximately $2.26 million under a pre-arranged Rule 10b5-1 trading plan.

IonQ's Chief Legal Officer and Corporate Secretary, Paul T. Dacier, was granted 9,432 restricted stock units, aligning his interests with long-term shareholder value.

IonQ Director Kathryn K. Chou has filed a Form 4 indicating a pre-scheduled sale of 6,789 shares of common stock on July 11, 2025, executed under a Rule 10b5-1 trading plan.

IonQ's Chief Financial Officer, Thomas G. Kramer, has filed a Form 4 indicating a future sale of 43,382 shares of common stock on July 8, 2025, under a pre-arranged Rule 10b5-1 trading plan.

IonQ's Chief Revenue Officer, Rima Alameddine, executed a pre-planned sale of 45,000 common shares at $46.18 per share after exercising options at $4.65, as part of a Rule 10b5-1 trading plan.

IonQ's Chief Financial Officer, Thomas G. Kramer, sold 72,000 shares of common stock for a weighted average price of $42.2555 per share, executed under a Rule 10b5-1 trading plan.

IonQ Director Kathryn K. Chou completed a pre-scheduled transaction, exercising stock options and selling the acquired common stock as part of a Rule 10b5-1 trading plan.

IonQ's Executive Chair, Peter Hume Chapman, executed a pre-planned sale of 1,497,311 shares of common stock at a weighted average price of $39.931 after exercising an equivalent number of employee stock options.

IonQ, Inc. Director William F. Scannell was granted 5,513 restricted stock units as part of his compensation, aligning his interests with the company's long-term performance.

IonQ, Inc. Director Gabrielle B. Toledano was granted 5,513 shares of common stock in the form of Restricted Stock Units (RSUs) on June 18, 2025, as part of her compensation.

IonQ, Inc. Director Inder M Singh was granted 5,513 restricted stock units (RSUs) on June 18, 2025, aligning his interests with long-term shareholder value.

IonQ, Inc. Director Kathryn K. Chou was granted 5,513 restricted stock units (RSUs) on June 18, 2025, as part of her compensation.

IonQ, Inc. Director Robert T. Cardillo was granted 5,513 restricted stock units (RSUs) on June 18, 2025, aligning his interests with the company's long-term performance.

IonQ's Chief Financial Officer, Thomas G. Kramer, sold 216,000 shares of common stock for approximately $8.23 million on June 16, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.

IonQ, Inc.'s Executive Chair and Director, Peter Hume Chapman, executed pre-planned sales of over 4.4 million shares of common stock in mid-June 2025, generating approximately $171 million.

IonQ, Inc. Director Wendy Thomas executed a pre-planned transaction, exercising stock options and subsequently selling a portion of her common stock holdings.

Peter Hume Chapman, Executive Chair and Director of IonQ, Inc., sold 11,965 shares of common stock on June 11, 2025, at a weighted average price of $41.5954, solely to satisfy tax withholding obligations related to the vesting of restricted stock units.

IonQ Director Kathryn K. Chou exercised stock options and subsequently sold a portion of her shares on June 11, 2025, as part of a pre-established Rule 10b5-1 trading plan.

IonQ, Inc. Director Robert T. Cardillo sold 10,058 shares of common stock for approximately $404,500 under a pre-arranged Rule 10b5-1 trading plan.

IonQ Director Gabrielle B. Toledano sold 792 shares of common stock for $41.50 per share on June 11, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.

IonQ's President and CEO, Niccolo de Masi, has sold 2,597,500 shares of common stock for approximately $104.8 million, executed under a pre-arranged 10b5-1 trading plan.

IonQ's Chief Revenue Officer, Rima Alameddine, reported the sale of shares for tax obligations and the exercise and subsequent sale of shares under a pre-arranged trading plan.

IonQ's Chief Financial Officer, Thomas G. Kramer, executed a non-discretionary sale of 9,994 common shares on June 11, 2025, at a weighted average price of $41.5954, solely to cover statutory tax withholding obligations related to the vesting of restricted stock units.

IonQ Director Inder M Singh reported the exercise of stock options and subsequent sale of common stock on June 12, 2025, pursuant to a pre-arranged Rule 10b5-1 trading plan.

IonQ's President and CEO, Niccolo de Masi, sold 9,280 shares of common stock at $42.23 per share to satisfy tax withholding obligations related to restricted stock unit vesting, a non-discretionary transaction.

Rima Alameddine, Chief Revenue Officer of IonQ, Inc., sold shares to cover statutory tax withholding obligations related to vesting restricted stock units.

Peter Chapman, Executive Chair of IonQ, sold 12,069 shares of common stock on March 11, 2025, to cover statutory tax withholding obligations related to the vesting of restricted stock units.